Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy
Stopped early · Phase 3
Conditions studied: Oral Mucositis
In brief
The purpose of this study is to determine if the administration of Caphosol rinse, at the start of chemotherapy, will prevent the development of mucositis (greater than or equal to grade 2 in children, adolescents and young adults. This is a randomized, controlled trial.
Key facts
- Study ID
- NCT02539342
- Run by
- Medical College of Wisconsin
- People needed
- 1
- Starts
- 2016-10-01
- Expected to finish
- 2017-03-02
- Last updated by the study team
- 2020-03-09
Who can join
Age: any, up to 25. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Oncology patients, at initiation of their oncology therapy, who are at risk of developing oral mucositis during their scheduled cancer therapy, defined by meeting one or more of the following criteria:
- Patients receiving one or more of the following chemotherapy agents:
- Actinomycin D
- Carboplatin
- Cisplatin
- Cytarabine at doses > 1 gram/m2
- Daunorubicin
- Doxorubicin
- Methotrexate at doses > 1 gram/m2
- Mitoxantrone
- Age 0 to 25 years
- Voluntary written consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care
You may not qualify if…
- Patients receiving glutamine treatment for oral mucositis.
- Patients undergoing autologous or allogeneic hematopoietic cell transplantation are excluded from this study.
- Patients receiving concurrent Head \& Neck radiation therapy or within 6 weeks of completion of radiation therapy.
- Pregnant or lactating patients. The agent used in this study is not known to be teratogenic to a fetus, but has not been studies, and there is no information on the excretion of the agent into breast milk. All females of childbearing potential must have a blood test or urine study within 2 weeks prior to registration to rule out pregnancy.
- Known allergy to Caphosol
Where it is running
- Children's Hospital of Wisconsin — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.